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rf and Rab family GTPases regulate membrane
traffic in cells, yet little is known about how they
are targeted to distinct organelles. To identify
sequences in Arf-1 necessary for Golgi targeting, we
examined the localization of chimeras between Arf-1
and Arf-6. Here, we identify a 16–amino acid sequence
in Arf-1 that specifies Golgi targeting and contains a
motif (MXXE) that is important for Arf-1 binding to mem-
brin, an ER-Golgi SNARE protein. The MXXE motif is
A
 
conserved in all Arfs known to localize to the Golgi and
enables Arf-1 to localize to the early Golgi. Arf-1 lack-
ing these 16 aa can still localize to the late Golgi where
it displays a more rapid Golgi-cytosol cycle than wild-
type Arf-1. These studies suggest that membrin recruits
Arf-1 to the early Golgi and reveal distinct kinetic cycles
for Arf-1 at early and late Golgi determined by different
sets of Arf regulators and effectors.
 
Introduction
 
A fundamental problem in membrane traffic in the biosynthetic
and endocytic pathways is how organelles maintain their dis-
tinct composition of proteins and lipids in the face of continuous
addition and removal of membrane. This is accomplished in
part by the recruitment of cytosolic protein complexes, motors,
and other components responsible for receiving and producing
transport vesicles at the organelle. GTPases of the Rab and Arf
families play key roles in regulating the recruitment of these
protein complexes and influencing membrane lipid composition
on distinct organelles (Munro, 2002), but how Rabs and Arfs
target to specific organelles remains unclear.
Arfs are expressed in all eukaryotes and function in vari-
ous membrane trafficking events and in the maintenance of
organelle structure (Moss and Vaughan, 1995; Chavrier and
Goud, 1999). There are six mammalian Arfs, and Arf-1 and
Arf-6 are the least similar in amino acid sequence and the best-
characterized members of the Arf family. Arf-1 is primarily
localized to the Golgi complex where it regulates the binding
of cytosolic coat proteins, including coat protein I (COPI),
adaptor protein 1, and Golgi-localized, 
 

 
-ear–containing, Arf-
binding proteins (GGA) to Golgi membranes (Bonifacino and
Lippincott-Schwartz, 2003; Nie et al., 2003) and thus serves to
regulate membrane traffic in the ER-Golgi system (Lippincott-
Schwartz et al., 1998). Arf-6, by contrast, localizes to the
plasma membrane and a membrane recycling system at the cell
periphery (Donaldson, 2003).
An important characteristic of Arf-1 is that the inactive
protein (Arf-1-GDP) is largely cytosolic, whereas the activated
protein (Arf-1-GTP) is membrane bound. Arf proteins are all
myristoylated and it has been postulated that Arf-1-GDP ini-
tially docks on the membrane through this myristoyl moiety
before encountering the guanine nucleotide exchange factor
(GEF) that catalyzes exchange of GTP for GDP (Antonny et al.,
1997). Arf-1-GTP associates more tightly with the membrane
and can then recruit coat proteins to the membrane until it en-
counters a GTPase-activating protein (GAP) that stimulates GTP
hydrolysis and dissociation of Arf-1-GDP from the membrane.
In biochemical assays, all Arf proteins share com-
mon effector functions including: activation of phospholipase
D (Liang et al., 1997) and phosphatidylinositol 4-phosphate
5-kinase (Honda et al., 1999), recruitment of COPI to membranes
(Liang and Kornfeld, 1997), and binding to GGA (Takatsu et
al., 2002). Yet in cells, Arfs have distinct functions and local-
izations. Arf-1 localizes to the Golgi complex, regulates the as-
sembly of coat proteins onto membranes and mediates traffic in
the ER-Golgi system (Bonifacino and Glick, 2004). Arf-6 lo-
calizes to the endosomal/plasma membrane system and not the
Golgi and thus has no effect on regulating the assembly of
COPI onto the Golgi complex in vivo (Peters et al., 1995).
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Thus, it is through organelle-specific targeting that Arf proteins
attain their unique cellular functions.
In this study, we were interested in identifying amino
acid residues in the Arf-1 sequence that determine its specificity
for Golgi targeting and distinguish it from other Arf proteins,
especially Arf-6. Because Arf proteins are highly conserved in
structure (Goldberg, 1998; Pasqualato et al., 2001), we fol-
lowed an approach that has been used by us and others, generat-
ing chimeric Arfs by exchanging amino- and carboxy-terminal
portions of Arf-1 and Arf-6 and expressing them in cells (Liang
et al., 1997; Jones et al., 1999; Al-Awar et al., 2000). As a result
of this study, we identified a short sequence in Arf-1 containing
a Golgi targeting signal, and in the sequence we identified a mo-
tif (MXXE) that is critical in vitro and in vivo for Arf-1 binding
to membrin, an ER-Golgi SNARE protein. Because the MXXE
motif enables Arf-1 to localize to the early Golgi, we suggest
that membrin is an Arf-1 receptor at the early Golgi.
 
Results
 
Identification of the Golgi targeting 
sequence in Arf-1
 
A comparison of human Arf-1 and Arf-6 is shown in Fig. 1 A
where identical amino acid residues are shaded in gray and
positions of the 
 

 
-helices and 
 

 
-sheets derived from struc-
tural studies (Amor et al., 1994; Menetrey et al., 2000) are in-
dicated. To identify sequences in Arf-1 that are necessary for
its Golgi localization, chimeric proteins of Arf-1 and Arf-6
were constructed and their localization was examined in
COS-7 cells. Full-length Arf-1 localized to the juxtanuclear
Figure 1. Subcellular localization of Arf chimeras. (A) Numbering and secondary structural elements ( helices and  sheets) of human Arf-1 and Arf-6
are shown. Identical residues between Arf-1 and Arf-6 are shaded in gray. Residues marked in red indicate amino acids 101–116 and 97–112 of Arf-1
and Arf-6, respectively. (B, C, and E) COS-7 cells overexpressing GalT-GFP and HA-tagged Arf-1 (B), untagged Arf-6 (C), or untagged Arf-6-1-6 (E) were
untreated (Unt) or incubated in the presence of 20 g/ml nocodazole for 2 h (Nz). Cells were fixed and immunolabeled with antibodies against HA (B)
or Arf-6 (C and E) followed by Alexa 594 anti–mouse and anti–rabbit antibodies, respectively. Bars, 10 m. (D) Diagrams of chimeras of Arf-1 and Arf-6
are shown. Blue and yellow regions represent Arf-1 and Arf-6 sequences, respectively.  and  indicate ability to localize to the Golgi.
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region in a pattern similar to that of galactosyltransferase
(GalT)-GFP, a chimera of GFP and the transmembrane do-
main of a Golgi resident enzyme, GalT (Fig. 1 B, Unt). The
Golgi localization of Arf-1 was also observed when cells
were treated with nocodazole, a microtubule-disrupting drug
that causes Golgi fragmentation (Fig. 1 B, 
 

 
Nz). On the other
hand, in cells overexpressing Arf-6, Arf-6 localized primarily
to the plasma membrane, although some juxtanuclear labeling
near the Golgi region was also observed (Fig. 1 C, Unt). This
juxtanuclear staining was clearly not the Golgi because Arf-6
did not label the Golgi fragments after nocodazole treatment
(Fig. 1 C, 
 

 
Nz).
As summarized in Fig. 1 D, all the chimeras that in-
cluded amino acids 101–116 of Arf-1 localized to the Golgi
(Fig. 1 D, 1-1-6, 6-1-1, and 6-1-6). On the other hand, 1-6-6
and 6-6-1, which lacked this sequence did not localize to the
Golgi (Fig. 1 D). Most strikingly, Arf-6-1-6, the chimera con-
taining amino acid residues 101–116 of Arf-1 inserted into
the Arf-6 sequence (Fig. 1 D), clearly localized to the Golgi,
even after nocodazole treatment (Fig. 1 E), although some
plasma membrane labeling was also observed. These results
show that residues 101–116 of Arf-1 are sufficient to target
Arf-6 to the Golgi. However, we observed that Arf-1-6-1,
which contains amino acids 97–112 of Arf-6, also localized to
the Golgi (Fig. 1 D), indicating that additional sequences in
the amino- and carboxyl-terminal halves of Arf-1 could to-
gether confer Golgi localization. We made similar observa-
tions with these Arf chimeras expressed in HeLa and NRK
cells (unpublished data).
 
Arf-6-1-6 and Arf-1-6-1 are activated by 
a BFA-sensitive GEF and inactivated by a 
GAP on the Golgi membrane
 
An important characteristic of Arf-1 is that the inactive,
GDP-bound protein is in the cytosol whereas the active,
GTP-bound protein is membrane bound, and cycling of Arf-1
between its activated and inactivated states is critical for Arf-1
function. When cells are treated with brefeldin A (BFA), a
fungal toxin that inhibits Arf-GEFs that are associated with
the Golgi complex (Jackson and Casanova, 2000), Arf-1 dis-
sociates from Golgi membranes because activation of Arf-1
by GEF is inhibited, whereas GAP continues to inactivate
Arf-1. To examine whether Arf-6-1-6 and Arf-1-6-1 can
serve as substrates for GEFs and GAPs on the Golgi mem-
brane like Arf-1, the dissociation of these Arf chimeras from
the Golgi after addition of BFA were compared with that of
Arf-1. In untreated COS-7 cells, clear Golgi localizations of
Arf-6-1-6-GFP and Arf-1-6-1-GFP were observed (Fig. 2,
Unt). After addition of BFA, both Arf-GFPs dissociated from
the Golgi as rapidly as Arf-1-GFP (Fig. 2, BFA 2 min). These
results show that both Arf-6-1-6 and Arf-1-6-1 can be inacti-
vated through GTP hydrolysis by the GAP on the Golgi
membrane. Furthermore, it suggests that activation of Arf-
6-1-6 and Arf-1-6-1 is catalyzed by a BFA-sensitive Golgi
GEF because neither Arf chimeras bound to the Golgi in the
presence of BFA. Similar observations were made in HeLa
cells (unpublished data).
 
110
 
MXXE
 
113
 
 of Arf-1 is critical for Golgi 
targeting
 
To identify the amino acid residues in the Arf-1 sequence of
Arf-6-1-6 that are necessary for Golgi targeting, we made
amino acid substitutions converting the Arf-1 to the Arf-6 resi-
dues. There are 9 aa residues that are different between Arf-1
and Arf-6 in this region (Fig. 3 A). Substitutions of Arf-1 resi-
dues 101N, 105E, 108M, and 112A to Arf-6 residues D, Q, H,
and N, respectively (6-1-6-a, Fig. 3 A), had no significant effect
on Golgi localization (Fig. 3 B). In addition, single replacement
of 110M, 111L, 113E, 114D, or 116L of 6-1-6-a with corre-
sponding residues of Arf-6 revealed that the efficiency of Golgi
localization of 6-1-6-a was significantly decreased if 110M or
113E were changed (Fig. 3, A and B, 6-1-6-b and 6-1-6-d).
These results demonstrate that 
 
110
 
MXXE
 
113
 
 in Arf-1 is critical
for the Golgi targeting information contained in helix 
 

 
3. Ex-
amination of Arf sequences from yeast to human reveals that
the MXXE motif is conserved in all class I Arfs (Fig. 3 C), with
all that have been examined localizing to the Golgi membranes
(Stearns et al., 1990; Takeuchi et al., 2002). It is also present in
human Arf-like protein 1 (Arl1) that is also associated with the
Golgi (Icard-Liepkalns et al., 1997; Lu et al., 2001), but is not
present in other Arls. Importantly, this motif is absent in all
class III Arfs (Fig. 3 C), which do not localize to the Golgi.
To show more clearly that amino acids 101–116 of Arf-1
contain sufficient information for Golgi targeting, 101–116 of
Arf-1 was fused to the carboxyl terminus of GFP (Fig. 4 A) and
the subcellular localization of the fusion protein was examined
in HeLa cells. Strikingly, in some cells expressing the GFP fu-
sion protein at low to moderate expression levels, juxtanuclear
localization of GFP-Arf-1(101–116) was observed that colocal-
ized with 
 

 
-COP, a subunit of COPI (Fig. 4 B). Although the ef-
ficiency of Golgi targeting of GFP-Arf-1(101–116) was low
Figure 2. BFA-induced redistribution of Arf-6-1-6 and Arf-1-6-1. COS-7
cells overexpressing GFP-fused Arf-1, Arf-6-1-6, or Arf-1-6-1 were untreated
(Unt) or incubated in the presence of 5 g/ml BFA for 2 min and fixed.
Bar, 10 m.
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(observed in 5–10% of transfected cells), this result confirmed
that 101–116 of Arf-1 is sufficient by itself to target to the
Golgi, because GFP alone localized to the cytosol and never
showed juxtanuclear localization (unpublished data). Moreover,
in cells expressing GFP-Arf-1(101–116) at a higher level and
showing juxtanuclear localization of the GFP fusion protein, the
distribution of GM130, a Golgi matrix protein, was clearly dif-
ferent than in untransfected cells. In untransfected cells, GM130
localized to interconnected, ribbon-shaped elements (Fig. 4 C,
inset I). This pattern was also observed in Arf-1-GFP–trans-
fected cells (not depicted). In contrast, in cells showing juxtanu-
clear localization of GFP-Arf-1(101–116), the distribution of
GM130 was changed into punctate structures (Fig. 4 C, inset
II). Moreover, high level expression of GFP-Arf-1(101–116)
caused COPI to dissociate from the Golgi complex (Fig. 4 D).
These results suggest that overexpressed GFP-Arf-1(101–116)
competes with endogenous Arf-1 for binding to the Golgi, and
inhibits Arf-1 regulation of maintenance of Golgi structure and
recruitment of COPI onto the Golgi complex.
 
Arf-1, but not Arf-1-6-1, binds to 
membrin on Golgi membranes
 
In an attempt to identify the receptor on Golgi membranes that
specifically recognizes 101–116 of Arf-1, we considered po-
Figure 3. Identification of critical amino acids in residues 101–116 of Arf-1
for Golgi targeting of the Arf-6-1-6 chimera. (A) Sequence comparison of
residues 101–116 of Arf-1 and corresponding residues of Arf-6 and mutants
of Arf-6-1-6 are shown. Bold characters indicate residues unique to Arf-6.
(B) COS-7 cells overexpressing GalT-GFP and the Arf constructs indicated
were fixed and immunolabeled with antibodies against Arf-6 followed by
Alexa 594 anti–rabbit antibodies. 100 cells were counted and the fraction
of transfected cells that show clear colocalization of overexpressed Arf pro-
teins with GalT-GFP was noted. The result shown is the mean  SD for three
experiments. (C) Sequence comparison of residues 101–116 of Arf-1 and
corresponding residues of related proteins are shown. Bold characters
indicate residues identical to 110M and 113E of Arf-1.
Figure 4. Amino acid residues 101–116 of Arf-1 are targeted to the
Golgi. (A) Schematic representation of GFP-Arf-1(101–116). (B–D) HeLa
cells expressing GFP-Arf-1(101–116) were fixed and immunolabeled with
antibodies against -COP (B and D) or GM130 (C) followed by Alexa
594 anti–rabbit and anti–mouse antibodies, respectively. Cells expressed
GFP-Arf-1(101–116) at low to moderate level (B) or high level (C and D).
The transfected cells in C and D are outlined. Images I and II in C show
magnified views of boxed areas. Bars, 10 m.
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tential candidate receptors. Recently, Rein et al. (2002) showed
that SNAREs may act as an Arf receptor on membranes in
yeast. Using in vitro binding assays, they showed that Arf1p di-
rectly binds Bet1p, Sec22p, and Bos1p, SNAREs that function
in transport pathways between the ER and the Golgi. The asso-
ciation with Bet1p is independent of the nucleotide bound to
Arf1p (Rein et al., 2002), suggesting that the SNARE recruits
Arf1p-GDP to membranes where the exchange of GDP to
GTP, and thus the activation of Arf1p, takes place.
To test the possibility that those SNAREs act as Golgi
membrane receptors for Arf-1 in mammalian cells, we coex-
pressed rbet1, sec22b, membrin, and syntaxin5, which are the
mammalian homologues of Bet1p, Sec22p, Bos1p, and Sed5p,
respectively, with Arf-1-GFP in HeLa cells. As reported (Hay
et al., 1996, 1998), rbet1, membrin, and syntaxin5 mainly lo-
calized to the Golgi whereas sec22b localized to the ER. We
noticed that, although Arf-1 generally colocalized with all of
the Golgi-localized SNAREs (not depicted), Arf-1 localization
was tightly coincident with membrin (Fig. 5 E), raising the
possibility that Arf-1-GFP was directly binding to the overex-
pressed membrin and that membrin may be serving as an Arf-1
receptor in vivo.
To investigate whether membrin specifically interacts
with Arf-1 and could be the basis for Golgi targeting of Arf-1,
we used in vitro binding experiments. Arf-1 was expressed in
 
E. coli
 
 as His
 
6
 
-tagged proteins where the amino-terminal 17 aa
were replaced by the His
 
6
 
 affinity tag. We incubated affinity-
purified Arf proteins with HeLa cell lysate expressing membrin
in the presence of GDP. Assuming that the interaction between
Arf-1 and its receptor would not be strong, we used a cross-
linking reagent to cross-link the proteins bound to Arf. As
shown in Fig. 5 (A and C), membrin efficiently bound to Arf-1
in the presence of the cross-linker. However, Arf-1-6-1, which
lacks residues 101–116 of Arf-1 yet still localizes to the Golgi
(Fig. 1 D), did not bind to membrin. Furthermore, when 110M
and 113E (
 
110
 
MXXE
 
113
 
) were substituted with corresponding
residues of Arf-6, the Arf-1 mutant failed to bind membrin
(Fig. 5, B and D). We know that these mutations do not affect
the general conformation of His
 
6
 
-Arf-1, because both His
 
6
 
-Arf-
1-6-1 and His
 
6
 
-Arf-1
 
M110I, E113D
 
 bound to the VHS-GAT domain
of GGA as well as wild-type Arf-1 in the presence of GTP
 

 
S
(Fig. S1, A and B, available at http://www.jcb.org/cgi/content/
full/jcb.200409138/DC1). Moreover, circular dichroism (CD)
spectra of these Arf-1 mutants were essentially identical to that
of Arf-1 (Fig. S1 C). Although we could detect binding of de-
tergent-solubilized membrin to His
 
6
 
-Arf-1, we could not obtain
binding using recombinant membrin (unpublished data). This
might indicate that other proteins or membrane lipids are re-
Figure 5. Arf-1, but not Arf-1-6-1, interacts and colocal-
izes with membrin. (A–D) His6-tagged Arf-1 and Arf-1-6-1,
and Arf-1M110I, E113D were incubated with lysate from HeLa
cells expressing myc-membrin in the presence of GDP.
A cross-linking reagent DSP was added where indicated.
Arfs were recovered and proteins were analyzed by
immunoblotting. Shown is one experiment representative
of three (A) or two (B) performed with similar results. In C
and D, relative amount of membrin bound to His6-Arf for
replicate experiments was determined using a densitometer.
(E and F) HeLa (E) or NRK (F) cells overexpressing myc-
membrin and Arf-1-GFP or Arf-1-6-1-GFP were fixed and
immunolabeled with antibodies against myc followed by
Alexa 594 anti–mouse antibodies. Bar, 10 m. (F) Quan-
titative analysis of area overlap in the Golgi region for
NRK cells as described in Materials and methods. Error
bars are the mean  SD.
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quired for the interaction. Together, these results demonstrate
that Arf-1-GDP binds membrin, and the association with mem-
brin requires the MXXE motif of Arf-1.
Having demonstrated that Arf-1 can specifically bind to
solubilized membrin, we examined more carefully the extent of
colocalization of Arf-1 and membrin in intact cells. In HeLa
cells, we observed a high degree of colocalization between Arf-1
and membrin (Fig. 5 E). However, colocalization of Arf-1-6-1
with membrin was partial and some membrin-positive struc-
tures were clearly devoid of Arf-1-6-1 (Fig. 5 E, inset, arrow-
heads). We observed similar immunolocalization results in
NRK cells where we quantified the amount of colocalization
(see Materials and methods), and found that 80% of Golgi-
associated Arf-1 colocalized with membrin whereas only 41%
of Golgi-associated Arf-1-6-1 colocalized with membrin (Fig. 5
F). Importantly, if we mutated Arf-1-6-1 such that it now contained
the MXXE motif, 75% colocalization between Arf-1-6-1
 
MXXE
 
and membrin was now observed (Fig. 5 F). We also observed
near complete colocalization of membrin with GFP-Arf-1(101–
116) (unpublished data). These results suggest that Arf-1 can
bind to membrin in vitro and in vivo but requires the MXXE
motif. Arf-1-6-1, on the other hand, does not interact with
membrin and thus must localize to the Golgi by an alternative
mechanism.
Figure 6. Membrin “protects” Arf-1 from BFA-induced
redistribution. (A–C) COS-7 cells overexpressing myc-
membrin and Arf-1-GFP or Arf-1-6-1-GFP (A), myc-membrin
and Arf-1-HA (B), or Arf-1-GFP and myc-rbet1 or HA-
syntaxin5 (C) were untreated (Unt) or incubated in the
presence of 5 g/ml BFA for indicated times and fixed.
Cells were immunolabeled with antibodies against myc
(A), HA and -COP (B), or myc or HA (C) followed by
Alexa 594 anti–mouse (A and C), or Alexa 488 anti–
mouse and Alexa 594 anti–rabbit (B) antibodies. Bars,
10 m. (D and E) HeLa cells overexpressing Arf-1-GFP
alone (D, control) or Arf-1-6-1-GFP alone (E, control), or
with myc-membrin or myc-rbet1, or HA-syntaxin5 were
untreated or incubated in the presence of 5 g/ml BFA
for 2 min and fixed and processed for immunolabeling
with antibodies against myc or HA followed by Alexa
594 anti–mouse and anti–rabbit antibodies, respectively.
To quantify Golgi and non-Golgi pools of Arf-1-GFP, one
region of interest was drawn around Golgi and the other
region of interest was drawn around the rest of the cell
(representing total cellular fluorescence). The mean fluo-
rescence intensity associated with the Golgi and total cell
was measured for Arf-1-GFP. The total Arf-1-GFP fluores-
cence associated with the Golgi was expressed as a
fraction of the total cellular fluorescence, and this procedure
was repeated for 10 cells. Error bars are the mean  SD.
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The finding that Arf-1 could bind to membrin, both in
cells and in in vitro binding assays, suggested that Golgi-associ-
ated membrin could act as the initial receptor for Arf-1-GDP
before GEF-catalyzed nucleotide exchange. If this is true, it is
possible that overexpression of membrin would partially protect
Arf-1 from release from Golgi membranes during BFA treat-
ment. When Arf-1 or Arf-1-6-1 was expressed alone in COS-7
cells, a significant amount of Arf dissociated from the Golgi
within 2 min after BFA addition (Fig. 2, BFA 2 min). However,
if membrin was coexpressed with Arf-1, Arf-1 labeling of the
Golgi was still apparent after 2 min of BFA addition (Fig. 6 A).
Even after 4 min, Golgi localization of Arf-1 was still promi-
nent in membrin-transfected cells (Fig. 6 A, cell marked with
arrowhead), whereas the bulk of the Arf-1 was dissociated in
cells not coexpressing membrin (Fig. 6 A, cell marked with ar-
row). This association of Arf-1 with membrin was lost as Golgi
membranes redistributed into the ER (see below). On the other
hand, in Arf-1-6-1–transfected cells, overexpressed membrin
did not protect the dissociation of Arf-1-6-1 from the Golgi by
BFA (Fig. 6 A), suggesting that the 16 aa of Arf-1 including the
MXXE motif were required for this effect. Overexpression of
membrin did not affect COPI dissociation after BFA addition
(Fig. 6 B), indicating that “protection” of Arf-1 dissociation did
not lead to GTP loading onto Arf-1. Because rbet1 and
syntaxin5 also showed Golgi localization in mammalian cells,
we examined whether overexpression of rbet1 or syntaxin5
would protect Arf-1 from dissociation by BFA. As shown in
Fig. 6 C, regardless of the level of expression, neither rbet1 nor
syntaxin5 affected the distribution of Arf-1 after BFA addition,
indicating that overexpression of these SNAREs did not retain
Arf-1 at the Golgi in COS-7 cells. We made similar observa-
tions in HeLa cells and quantified the amount of Arf-1 and Arf-
1-6-1 associated with the Golgi before and after BFA in cells
coexpressing these ER-Golgi SNAREs (Fig. 6, D and E). In un-
treated cells, 
 

 
17% of total cellular Arf-1 was associated with
the Golgi and this dropped to 6% after 2 min BFA (Fig. 6 D,
control). In cells expressing membrin however, Arf-1 associ-
ated with the Golgi drops only to 12% after BFA (Fig. 6 D,
 

 
membrin). On the other hand, neither rbet1 nor syntaxin5 ex-
pression affected the distribution of Arf-1 after BFA addition
(Fig. 6 D, 
 

 
rbet1 and 
 

 
syntaxin5). In Arf-1-6-1–transfected
cells, dissociation from the Golgi by BFA was similar in all
cases and not affected by expression of any SNARE (Fig. 6 E).
Together, these results indicate that membrin can specifically
recruit Arf-1-GDP to Golgi membranes and transiently “pro-
tect” Arf-1-GDP from BFA-induced dissociation. Furthermore,
that it is Arf-1-GDP that is binding to membrin is supported by
the observation that Arf-1 Q71L did not colocalize with mem-
brin in cells (unpublished data).
 
Arf-1 and membrin colocalize on COPI-
coated transport structures between 
the ER and Golgi
 
Having demonstrated that membrin appears to represent an ini-
tial Arf-1-GDP binding site on Golgi membranes, we won-
dered where the interaction occurs. Membrin is involved in the
membrane transport pathway between the ER and the Golgi
complex (Hay et al., 1997). Arf-1 also has been shown to func-
tion in this system (Dascher and Balch, 1994; Ward et al.,
2001). These findings raise the possibility that both proteins
might interact on transport structures from the ER to the Golgi.
Discerning Arf-1 localization on peripheral, incoming ER to
Golgi transport structures was difficult due to the Arf-1 pres-
ence in the cytosol. Therefore, we examined the distribution of
membrin and Arf-1 during recovery from BFA in NRK cells, a
process that involves rapid and massive anterograde membrane
transport from the ER, resulting in reformation of the Golgi
complex (Lippincott-Schwartz et al., 1990). After 30 min of
BFA treatment, Arf-1 was cytosolic, whereas membrin local-
ized to small, peripheral structures (Fig. 7 A, BFA) that colo-
calized with ERGIC53/p58 (unpublished data) and thus were
ER exit sites (Tang et al., 1995; Ward et al., 2001). 10 min after
BFA wash out, Arf-1 now colocalized with membrin on scat-
tered peripheral structures (Fig. 7 A, WO 10 min). 
 

 
-COP was
also distributed on those structures, indicating that Arf-1 was
activated and recruited COPI onto the structures (Fig. 7 B).
After 15 min of recovery, most of the membrin and Arf-1 colo-
calized on larger juxtanuclear structures, although some small,
peripheral structures were still observed (Fig. 7 A, WO 15 min).
Arf-1-6-1 also showed cytosolic distribution in BFA-treated
cells similar to Arf-1 (Fig. 7 A, BFA). However, 10 min after
BFA wash out, the distribution of Arf-1-6-1 was still cytosolic,
whereas membrin was observed on peripheral structures (Fig. 7
A, WO 10 min). Although some Arf-1-6-1 weakly colocalized
with membrin on the juxtanuclear structures after 15 min of re-
covery, a major part of Arf-1-6-1 was still cytosolic and some
membrin-positive transport structures were clearly devoid of
Arf-1-6-1 (Fig. 7 A, WO 15 min, inset, arrowheads). After a
20-min recovery, Arf-1-6-1 could be observed to colocalize
with membrin on the fully reassembled, juxtanuclear Golgi
complex (Fig. 7 A, WO 20 min). Similar recruitment of Arf-1,
but not Arf-1-6-1, to reforming Golgi structures was observed
in COS-7 cells (unpublished data). The delay in recruitment of
Arf-1-6-1 to the reforming Golgi did not slow Golgi recovery
because endogenous Arf-1 could be recruited. Together, these
results demonstrate that these 16 aa and the MXXE motif of
Arf-1 allow Arf-1 recruitment to membrin-containing transport
structures bound for the Golgi complex.
 
Arf-1-6-1 localizes to the trans-Golgi, 
but not to the cis-Golgi, and is regulated 
differently from Arf-1
 
Because Arf-1-6-1 did not associate with reforming Golgi dur-
ing BFA wash out (Fig. 7 A), we wondered how and where
Arf-1-6-1 is recruited to the Golgi. The Golgi complex can be
divided into cis- and trans-sides, shown to have distinct func-
tions (Bonifacino and Glick, 2004). Golgi-specific BFA resis-
tance factor 1 (GBF1) and BFA-inhibited GEF (BIG) 1/2 are
Arf-GEFs known to localize mainly to cis-and trans-elements
of the Golgi, respectively, and limited overlap between the dis-
tribution of GBF1 and BIG1 has been observed (Yamaji et al.,
2000; Kawamoto et al., 2002; Shinotsuka et al., 2002a,b; Zhao
et al., 2002). Indeed, double staining of NRK cells with anti-
bodies for GBF1 and BIG1 confirmed the feasibility of dis-
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tinguishing the distributions of these Arf-GEFs at the light
microscopy level (unpublished data). To identify more specifi-
cally the distributions of Arf-1 and Arf-1-6-1 in the Golgi com-
plex, we compared their distributions to the localizations of
GBF1 or BIG1. The distribution of Arf-1 overlapped exten-
sively with that of GBF1 with nearly superimposable images
(Fig. 8 A). By contrast, Arf-1-6-1 overlapped less with GBF1
(Fig. 8 A). Quantifying the extent of colocalization revealed
that 82% of the Golgi-associated Arf-1 colocalized with GBF1
whereas only 38% of the Golgi-associated Arf-1-6-1 colo-
calized with GBF1 (Fig. 8 B). On the other hand, Arf-1-
6-1 seemed to colocalize more with BIG1 at the trans-Golgi
than did Arf-1 (59% and 38% overlapping, respectively; Fig. 8,
C and D). Importantly, mutagenesis of Arf-1-6-1 to include
MXXE shifted the colocalization of Arf-1-6-1
 
MXXE
 
 back to that
observed with Arf-1, 72% colocalized with GBF1 (Fig. 8 B)
and 38% colocalized with BIG1 (Fig. 8 D). These results dem-
onstrate that Arf-1-6-1 localizes mainly to the trans-Golgi, and
not to the cis-Golgi. Because the distribution of membrin was
almost identical to that of GBF1, whereas membrin did not
colocalize well with BIG1 (unpublished data), these results
suggest that interaction with membrin may be required for Arf-1
to localize to the cis-Golgi.
Although our data suggest that Arf-1 binding to membrin
is the mechanism for recruitment of Arf-1 to the early Golgi, it
is possible that Arf-1 is recruited to the cis-Golgi through direct
Figure 7. Anterograde movement of membrin and Arf-1 into the Golgi in BFA-recovering cells. (A) NRK cells overexpressing myc-membrin and Arf-1-GFP
or Arf-1-6-1-GFP were incubated in the presence of 5 g/ml BFA for 30 min, washed free of BFA, and incubated in the absence of BFA for the indicated
times of wash out (WO) and fixed. Cells were immunolabeled with antibodies against myc followed by Alexa 594 anti–mouse antibodies. (B) NRK cells
overexpressing myc-membrin were treated as in A and fixed. Cells were immunolabeled with antibodies against myc and -COP followed by Alexa 488
anti–mouse and Alexa 594 anti–rabbit antibodies. Bars, 10 m.
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interaction and activation by GBF1. Arf-1-6-1 might not bind
to the early Golgi because it cannot interact with GBF1 due to
its Arf-6 sequence. Indeed, some Arf-GEFs may recognize
subtle folding differences between Arf-1 and Arf-6 explaining
their selectivity for different Arfs (Macia et al., 2001). To ex-
amine whether Arf-1-6-1 can be activated by GBF1, we mea-
sured the amount of GTP-bound Arf-1 and Arf-1-6-1 in cells
overexpressing HA-tagged GBF1 (see Materials and methods).
As shown in Fig. S2 (available at http://www.jcb.org/cgi/
content/full/jcb.200409138/DC1), overexpressed GBF1 activated
Arf-1-6-1, although not to the same extent as Arf-1, suggesting
that Arf-1-6-1 can be activated by GBF1 in cells.
In addition to GEFs, distinct GAPs may regulate Arf-1 at
the Golgi in mammalian cells (Cukierman et al., 1995; Miura et
al., 2002). It is likely that distinct GEFs and GAPs regulate Arf-1
at cis- and trans-elements of the Golgi complex. Having demon-
strated that Arf-1-6-1 localizes mainly to the trans-Golgi, and
not to the cis-Golgi, we wondered if Arf-1-6-1 is regulated dif-
ferently from Arf-1. FRAP is a powerful technique to examine
the kinetics of dissociation and association of Arf-1 at the Golgi
in live cells (Vasudevan et al., 1998; Presley et al., 2002). Be-
cause the kinetics reflect GAP and GEF activities on Arf-1, we
examined the FRAP of the Golgi region in Arf-1-GFP- and Arf-
1-6-1-GFP–transfected cells. Representative FRAP kinetic data
are shown in Fig. 9 A. The recovery of Arf-1-GFP fluorescence
showed kinetics (
 
t
 
1/2 
 
 
 
20 s) similar to previous studies (Presley
et al., 2002). By contrast, the recovery kinetics of Arf-1-6-1-
GFP (
 
t
 
1/2 
 
 
 
10 s) was much more rapid, indicating that Arf-1-6-1
spends less time on the Golgi per cycle than Arf-1. Because
Arf-1-6-1 primarily localizes to the late Golgi (Fig. 8), the dif-
ference in the FRAP data for Arf-1 and Arf-1-6-1 suggests that
Arf-1 cycling at the trans-Golgi might be faster than at the cis-
Golgi. We hypothesized that failure to bind to membrin at the
early Golgi leads to Arf-1-6-1 being activated and inactivated at
the late Golgi with more rapid kinetics. To test this, we mea-
sured the FRAP kinetics of Arf-1-6-1
 
MXXE
 
-GFP and observed
that Arf-1-6-1
 
MXXE
 
-GFP now exhibited FRAP kinetics (
 
t
 
1/2 
 

 
20 s) identical to that of wild-type Arf-1 (Fig. 9 A).
Figure 8. Comparison of the distribution of Arf-1 and Arf-1-6-1 to Arf-GEFs. NRK cells overexpressing GFP-fused Arf-1, Arf-1-6-1, and Arf-1-6-1MXXE were
fixed and immunolabeled with antibodies against GBF1 (A) or BIG1 (C) followed by Alexa 594 anti–mouse and anti–rabbit antibodies, respectively.
Bars, 10 m. (B and D) Quantitative analysis of area overlap in the Golgi region as in A and C. Error bars are the mean  SD.
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Discussion
 
We have identified a 16–amino acid region in Arf-1 that is nec-
essary and sufficient for Arf-1 targeting to the early Golgi.
These 16 aa include helix 
 

 
3 (Fig. 1 A) and contains a motif
(MXXE) that is found in all Arfs known to associate with the
Golgi complex, and in all eukaryotes examined. Membrin, an
ER-Golgi SNARE, binds Arf-1-GDP via the helix 
 

 
3 and is re-
sponsible for recruiting Arf-1 to the early Golgi. An Arf-1 mu-
tant lacking this region (Arf-1-6-1) cannot bind membrin and
does not localize to the early Golgi although it does associate
with the late Golgi through other means that require both amino-
and carboxyl-portions of the protein. Although SNAREs are be-
lieved to function in membrane fusion events (Hay, 2001; Boni-
facino and Glick, 2004), our results show an additional role of
membrin as a membrane receptor for Arf-1 at the Golgi. Because
Bos1p, the yeast homologue of membrin, has also been shown
to interact with Sar1p, a component of the coat protein II
(COPII) coat (Springer and Schekman, 1998), membrin recruit-
ment of Arf-1 might coordinate the exchange of Sar1/COPII to
Arf-1/COPI coats on incoming, pre-Golgi structures.
The first suggestion that ER-Golgi SNAREs could recruit
Arf-1 came from in vitro binding studies in yeast (Rein et al.,
2002) showing that nonmyristoylated, 
 
	
 
17Arf1p-GDP could
bind directly to GST fusion proteins of Bet1p, Sec22p, and
Bos1p. In that study, Arf1p binding to Bet1p was stronger than
to Bos1p and, curiously, required the presence of an Arf-GAP
protein, Glo3p, to prime the SNAREs (Rein et al., 2002).
Our study shows that membrin, but not rbet1, sec22b or syn-
taxin5, can bind specifically to full-length, myristoylated Arf-1
through the MXXE motif in mammalian cells. Because our
cells express mammalian ArfGAP1, it is possible that this en-
dogenous GAP could function in vivo to prime membrin for
Arf-1 binding. Interestingly, the proximal region of helix 
 

 
3
makes contact with ArfGAP1 in a co-crystal of 
 
	
 
17Arf-1-GDP
and the GAP domain of ArfGAP1 (Goldberg, 1999), raising
the possibility that the recruitment of Arf-1 to the early Golgi
by membrin might also involve ArfGAP1. Because yeast Arf1p
also contains MXXE, and can be recruited to Golgi when ex-
pressed in mammalian cells (unpublished data), this motif may
be used for Golgi targeting in yeast cells. Indeed, evidence that
the 
 

 
3 region in yeast promotes Golgi recruitment of Arf-1
comes from a genetic study that identified amino acid residues
in the distal portion of helix 
 

 
3 as an intragenic suppressor of a
dominant lethal mutation (Click et al., 2002).
The other class of Golgi membrane proteins that have
been suggested to serve as Arf-1 receptors are the abundant
p23 and p24 family proteins. The p23 protein was shown by
chemical cross-linking to bind directly to Arf-1-GDP, but not
to Arf-1-GTP, in vitro and the interaction site was mapped to
the carboxyl-terminal 22 aa (Gommel et al., 2001). Although
this interaction was also observed in an in vivo study examin-
ing fluorescence resonance energy transfer between p23-CFP
and Arf-1-YFP (Majoul et al., 2001), it may not represent the
interaction that targets Arf-1-GDP specifically to the Golgi.
We did not detect a Golgi targeting motif in the last 22 aa of
Arf-1 because Arf-6-6-1, which lacked the 16–amino acid se-
quence and the amino-terminal half of Arf-1 but contained
Arf-1 sequence from 117–181, did not localize to the Golgi
(Fig. 1 D). Our data suggest that membrin serves as a specific
receptor for Arf-1-GDP. However, it does not preclude an in-
teraction of Arf-1-GDP with p23 proteins either simulta-
neously or subsequently during the interaction cycle of Arf-1
with Golgi membranes.
Arf proteins are highly conserved both in sequence and in
structure with nearly identical switch I and II regions (Gold-
berg, 1998; Pasqualato et al., 2001). Helix 
 

 
3 is positioned on
the “backside” of the molecule, on the opposite side of the GTP
binding pocket. It alone appears to contain sufficient information
for Golgi targeting (Fig. 4) and presumably membrin binding.
In the context of the Arf-1 protein, the MXXE motif in helix 
 

 
3
appears to be required for Golgi targeting. We do not know
Figure 9. Arf-1 and Arf-1-6-1 are regulated differently at Golgi mem-
branes. (A) The kinetics of recovery of GFP-fused Arf-1, Arf-1-6-1, and Arf-
1-6-1MXXE in the Golgi region after photobleaching are shown. The Golgi
regions of cells expressing Arfs-GFP were photobleached at maximal laser
intensity. Immediately after the bleach, cells were scanned every 5 s. The
fluorescence intensity in the bleach area was measured. Shown is one
experiment representative of three performed with similar results. (B)
Models for membrane association/dissociation cycle of Arf-1 and Arf-1-6-1.
See text for details.
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whether the M or E make direct contact with membrin, but they
are necessary for Arf-1 binding to membrin.
We propose that in the ER-Golgi system, membrin re-
cruits Arf-1-GDP to the membrane subsequent to the release of
the COPII coat (Fig. 9 B, I). Arf-1-GDP is then activated by
GBF1, the early Golgi GEF, and Arf-1-GTP can then recruit
coatomer or other effectors and Arf-GAP, leading to GTP hy-
drolysis and release of Arf-1-GDP back into the cytosol. The
Arf-1 construct that cannot bind to membrin (Arf-1-6-1) can
still associate with the Golgi complex, possibly by direct inter-
action with an Arf-GEF such as BIG1 and 2, which are known
to reside at the trans-Golgi (Fig. 9 B, II; Shinotsuka et al.,
2002a,b; Zhao et al., 2002). Arf-1-6-1 colocalizes less with
GBF1 (Fig. 8, A and B) and, during recovery from BFA, Arf-
1-6-1 cannot associate with the peripheral, COPI-labeled, re-
forming Golgi structures (Fig. 7 A). Intriguingly, we observed
a distinct difference between the FRAP kinetics of Arf-1 and
Arf-1-6-1 (Fig. 9 A). Namely, that Arf-1-6-1-GFP had a much
shorter recovery time after photobleaching (
 
t
 
1/2 
 
 
 
10 s) than did
Arf-1-GFP (
 
t
 
1/2 
 
 
 
20 s). We speculate that the shorter residency
time for Arf-1-6-1 could be due to interaction with trans-Golgi
GEFs (BIG1 and 2) and GAPs. In contrast, the residency time
of Arf-1 on the Golgi is longer and includes interaction of Arf-1
with membrin, GBF1 and ArfGAP1 at early Golgi. These dif-
ferences in kinetic cycles may reflect the different GEFs and
GAPs residing at the early and late Golgi (Fig. 9 B, I, II).
 
Functional relationship between Arf-1 
and SNAREs
SNAREs have an essential role in regulating membrane fusion
events throughout the secretory pathway (Hay, 2001; Bonifa-
cino and Glick, 2004). SNAREs form cytoplasmic coiled-coil
bundles that bridge two membranes about to undergo mem-
brane fusion. Furthermore, as SNAREs are compartment spe-
cific and can engage in various SNARE pair conformations,
they have the potential to serve as exquisite membrane recep-
tors for cytosolic components such as COPI and COPII compo-
nents whose regulated assembly controls vesicle formation.
Current models for transport in the early secretory path-
way depict secretory cargo and the SNAREs syntaxin5, rbet1,
and membrin being recruited into COPII vesicle budding from
the ER (Fig. 9 B, I; Springer and Schekman, 1998). Our obser-
vations that Arf-1 cannot bind to membrin when it is in the ER
or at ER exit sites, i.e., 30 min BFA (Fig. 7) suggest that the al-
tered conformation of membrin in the ER or association with
the COPII coat may prevent Arf-1 binding. The tethering pro-
tein p115 associates with these newly budded vesicles by bind-
ing directly to the SNAREs in a Rab1-dependent fashion (Al-
lan et al., 2000). At the Golgi, p115 and these SNAREs are
believed to facilitate fusion of pre-Golgi structures to Golgi
membranes or to other incoming pre-Golgi structures. GBF1
associates with p115 (Garcia-Mata and Sztul, 2003) and has
been shown to be involved in COPI recruitment onto mem-
branes (Claude et al., 1999; Kawamoto et al., 2002). Further-
more, GBF1 is essential for COPI recruitment to the transport
intermediates bound for the Golgi (Garcia-Mata et al., 2003).
These observations support the idea that p115 and membrin
might coordinately recruit GBF1 and Arf-1-GDP onto the post-
ER, transport structure, leading to Arf-1 activation and the re-
cruitment of COPI (Fig. 9 B, I).
Materials and methods
Cells, antibodies and reagents
Cells were grown in DME supplemented with 10% FBS, 100 U/ml penicil-
lin, and 100 g/ml streptomycin at 37
C with 5% CO2. Rabbit anti–Arf-6
antibody that recognizes a carboxyl-terminal peptide of the protein was
used as described previously (Radhakrishna and Donaldson, 1997). Rab-
bit anti-BIG1 antibody was provided by C.L. Jackson (NIH; Yamaji et al.,
2000). Monoclonal antibodies against the HA epitope (16B12) and the
myc epitope (9E10) were purchased from Covance and Zymed Laborato-
ries, respectively. Monoclonal anti-GM130 and anti-GBF1 antibodies
were purchased from BD Biosciences. Rabbit anti–-COP antibody was
purchased from Affinity BioReagents, Inc. Secondary antibodies (Alexa
594, Alexa 488, anti–mouse, and anti–rabbit) were purchased from Mo-
lecular Probes. Dithiobis(succinimidyl propionate) (DSP) was purchased
from Pierce Chemical Co. E. coli containing a vector for GST-fusion pro-
teins comprising VHS-GAT domain of human GGA3 was provided by J.S.
Bonifacino (NIH; Dell’Angelica et al., 2000). All other reagents were pur-
chased from Sigma-Aldrich.
Plasmids and transient transfections
The chimeras of Arf-1 and Arf-6 were created by a two-step PCR proce-
dure as described previously (Al-Awar et al., 2000). All other mutants of
Arf-1 and Arf-6 were created using QuickChange site-directed mutagene-
sis kit (Stratagene). The cDNAs of untagged or carboxyl-terminally HA-
tagged wild-type and mutant Arf were subcloned into the modified pCDL-
SR expression vector (Takebe et al., 1988) or pEGFP-N1 vector (CLON-
TECH Laboratories, Inc.). Amino acids 101–116 of Arf-1 were shuttled
into pEGFP-C3 vector (CLONTECH Laboratories, Inc.). The plasmids for
amino-terminally myc-tagged membrin, rbet1, sec22b, and HA-tagged
syntaxin5 were created as described previously (Hay et al., 1996, 1997).
The plasmids for GalT-GFP and HA-tagged GBF1 were provided by J. Lip-
pincott-Schwartz (NIH; Cole et al., 1996) and C.L. Jackson, respectively.
Cells were grown on glass coverslips and transfected using Fu-
GENE 6 (Roche) according to the manufacturer’s instructions. For FRAP
experiments, HeLa cells were plated in Lab-Tek chambered coverglass
(Nalge Nunc International).
Confocal microscopy
20 h after transfection, cells were treated as indicated, fixed, and sub-
jected to immunofluorescence staining in the presence of 0.2% saponin as
described previously (Radhakrishna and Donaldson, 1997). All fluores-
cence images were obtained with a confocal microscope (model LSM
510; Carl Zeiss MicroImaging, Inc.). Most images of fixed cells were cap-
tured using 63 1.4 NA objective with a pinhole corresponding to a fo-
cal depth of 0.7 m. To quantify Golgi-associated Arf-1-GFP, a 40 0.7
NA objective was used with a pinhole corresponding to a focal depth of
12.4 m. For FRAP experiments, cells were incubated in CO2-indepen-
dent media (Invitrogen), and imaged at 20
C on a confocal microscope
(model LSM 510; Carl Zeiss MicroImaging, Inc.) using a 40 0.7 NA ob-
jective with a pinhole corresponding to a focal depth of 2.5 m. Image
processing for figures was accomplished in Adobe Photoshop 5.5.
Analysis of colocalization
To quantify the level of colocalization for Golgi-associated Arfs with mem-
brin, GBF1, and BIG1, 20 cells were randomly selected on the same cov-
erslip. Levels for the laser power and detector amplification were opti-
mized for each channel before starting the quantification. Images of the
Golgi region were acquired at the same magnification and processed by
Metamorph 4.6 (Universal Imaging Corp.).
In vitro binding experiments
To examine the interaction between His6-Arf-1 and membrin, HeLa cells
overexpressing myc-membrin were lysed in binding buffer (25 mM Hepes,
pH 7.5, 100 mM NaCl, 0.5 mM EDTA, 1 mM MgCl2, 1 mM DTT, 1 mM
AEBSF, 3 g/ml leupeptin, 3 g/ml aprotinin, 3 g/ml pepstatin A) con-
taining 0.5% Triton X-100. Supernatants of the lysate were incubated with
His6-tagged 	17Arf-1 prebound to Ni-NTA beads (QIAGEN) in the pres-
ence of 1 mM GDP for 3 h at 4
C, and cross-linking reagent DSP was
added at a final concentration of 1 mM. After incubation for 20 min at RT,
JCB • VOLUME 168 • NUMBER 7 • 20051050
DSP activity was quenched by addition of 50 mM glycine. The beads
were washed and the proteins bound to beads were subjected to SDS-
PAGE and immunoblot analysis with anti-myc antibody.
Online supplemental material
Fig. S1 shows that Arf-1-6-1 and Arf-1M110I, E113D when loaded with GTPS
could bind to GST-VHS-GAT as well as wild-type Arf-1. Also, measurement
of CD spectra of these Arf-1 mutants demonstrated that the general confor-
mations of Arf-1-6-1 and Arf-1M110I, E113D are essentially identical to that of
Arf-1. Fig. S2 shows that overexpressed GBF1 can activate Arf-1-6-1 in
cells. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200409138/DC1.
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